(Q54352037)

28 May 2018

title

Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. (English)

1 reference

28 May 2018

author name string

E A Olsen

1

1 reference

28 May 2018

F F Kelly

2

1 reference

28 May 2018

R T Vollmer

3

1 reference

28 May 2018

D A Buddin

4

1 reference

28 May 2018

P K Weck

5

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 June 1989

1 reference

28 May 2018

Journal of the American Academy of Dermatology

published in

1 reference

28 May 2018

volume

20

1 reference

28 May 2018

issue

6

1 reference

28 May 2018

page(s)

1023-1030

1 reference

28 May 2018

Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Latent papillomavirus and recurring genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Interferons in the treatment of skin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Interferon therapy for condylomata acuminata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Intralesional human lymphoblastoid interferon alpha for the treatment of cutaneous, nongenital viral warts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Interferon in the treatment of persistent viral warts.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Treatment of verrucae vulgaris with alpha 2 interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Intralesional administration of large doses of human leukocyte interferon for the treatment of condylomata acuminata

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Interferon for the therapy of condyloma acuminatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alpha 2 interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Effect of oral aromatic retinoid (Ro 10-9359) on human papilloma virus-2-induced common warts.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

Treatment of extensive virus warts with etretinate (Tigason) in a patient with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

The human papillomaviruses. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2889%2970127-4

7 January 2021

10.1016/S0190-9622(89)70127-4

Identifiers

DOI

1 reference

28 May 2018

PubMed ID

2754052

1 reference

28 May 2018